Contact Us...

USF Breast Health
3000 Medical Park Dr.
Suite 140
Tampa, FL  33613

Phone:  813-793-4272
Fax:  813-374-9495

Directions...

Click on the following link for a Google Map to USF Breast Health:





Fundraising...


Car Shows for Charity

USF Foundation Web Site


Technology

     The USF Breast Health Program is committed to using the latest technologies for treating breast cancer.  The following is a list of some of the technology currently in use.


Cryoablation Therapy

Cryoablation kills tumor cells by freezing them.  This may be an effective treatment for patients with invasive ductal breast cancer.

This is a clinical trial that is currently in progress.  Please click on the following link for more information:   

http://www.clinicaltrials.gov/ct2/show/NCT00723294?term-cryoablation&rank=15

Dr. John Cox, of Tampa Bay Breast Care Specialists, recently recorded a video of the Cryoablation procedure for PBS, which aired on March 18, 2011.  Please click on the following link to view it.

http://www.pbs.org/wnet/need-to-know/health/video-six-women-many-small-steps-toward-breast-cancer-breakthroughs/8232


HALO Breast Pap Test

  • HALO is noninvasive, objective and repeatable, plus it's quick - just 5 minutes
  • HALO has been proven a safe and effective method to collect nipple aspirate fluid for analysis
  • Routine assessment with HALO will enable breast health monitoring and the ability to react to cellular changes early
     The HALO® Breast Pap Test is FDA approved for the collection of nipple aspirate fluid for cytological evaluation. The collected fluid can be used in the determination and/or differentiation of normal versus pre-malignant versus malignant cells.

    
Incorporating Halo into routine practice will enable physicians and patients to monitor cellular changes within breast ducts earlier, before they develop into larger, potentially cancerous lesions.
                             

Xoft Axxent® eBx System for breast brachytherapy:

    
The Xoft Axxent® eBx System for breast brachytherapy is designed to simplify the radiation therapy procedure and increase accessibility to patients who are suitable candidates for partial-breast irradiation (PBI). Breast eBx with the Axxent System delivers a prescribed, targeted dose of radiation directly to the site where cancer recurrence is most likely. Compared to traditional radiotherapy, eBx requires fewer treatments and minimizes exposure to healthy tissue and organs, such as the ribs, lungs, heart and opposite breast (Reduced Dose to Heart and Lungs). Patients also experience low rates of serious complications and favorable cosmetic outcomes.
 



MammaPrint gene expression profiling system:  

   MammaPrint is a gene expression profiling system to assess the risk of cancer recurrence in patients with breast cancer. The system is based on the expression of 70 of the most informative genes in the tumor, quantified simultaneously to ensure a high degree of accuracy in determining the risk of breast cancer recurrence.  MammaPrint result are indicated for use by physicians as a prognostic marker in combination with other clinical information and laboratory tests. MammaPrint is also the first in vitro diagnostic multivariate index assay (IVDMIA) to acquire market clearance from the FDA.

USF Breast News

Molecular subtyping of breast cancer may better identify women at high risk of disease recurrence. 
03/07/2014 Tampa, FL
A method called molecular subtyping can help doctors better determine which of their patients are at a high risk of getting breast cancer again...

USF Breast Health and Tampa Bay Breast Care Specialists have teamed up on a new Cryoablation Study 
05/17/2013 Tampa, FL
Cryoablation is a new technique that holds the promise of a breakthrough in the treatment of early stage breast cancer...

Florida Hospital and USF Health Form Partnership in Key Specialties to Expand Translational Medicine in Tampa bay
03/12/2012 Tampa, FL
Florida Hospital and USF Health have formed a strategic alliance, combining Adventist Health System's innovative approach to patient-centered care with the University of South Florida's leading research...

Charles E. Cox Recently Recognized by Srathmore's Who's Who Publication January, 2012, Westbury, N.Y.
Charles Cox, M.D., has recently been recognized as a Professional of the Year by Strathmore's Who's Who Registry  for his outstanding contributions and achievments in the field of Surgical Oncology...

 
 More news...